Bruker Corp (FRA:BKD)
€ 60.6 1.32 (2.23%) Market Cap: 9.12 Bil Enterprise Value: 10.17 Bil PE Ratio: 23.63 PB Ratio: 6.67 GF Score: 95/100

Bruker Corp at UBS Global Healthcare Virtual Conference Transcript

May 24, 2021 / 01:00PM GMT
Daniel Gregory Brennan;Miroslava Atanassova Minkova
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences;Bruker

Good morning. This is Dan Brennan from UBS Healthcare team. Apologies for the bit of a delay. We're still working out the kinks on day 1 of the U.S. -- day 1 of the UBS Healthcare conference. Glad you could join us. A few minutes behind, but we have some flexibility at the back end, really pleased to be joined with me here on the virtual stage with its senior management team, Bruker.

We have on the audio, Frank Laukien who doesn't need an intro, but President and Chief Executive Officer; and we have Mark Munch, who's President of Bruker Nano; and we have Miroslava Minkova, who is Head of Investor Relations.

So feel free to send me emailed questions. I think any of you on the webcast, there's probably a link to do so, but I've certainly got a list to go through here. So again, apologies for a bit of a delay here, but glad you could be with us.

Frank, Mark and Miroslava, welcome.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot